HealthDay on MSN11m
FDA Approves Omvoh for Moderately to Severely Active Crohn DiseaseThe U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback